Establishment Capital Stock from 2010 to 2024

ESTA Stock

USD 49.00 0.53 1.09%

Establishment Labs' Capital Stock is increasing over the years with slightly volatile fluctuation. Capital Stock is expected to dwindle to about 232.1 M. Capital Stock is the total amount of a company’s capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

315.6 M

Current Value

232.1 M

Quarterly Volatility

51.6 M

Credit Downgrade

Yuan Drop

Covid

Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment main balance sheet or income statement drivers, such as Interest Income of 568 K, Interest Expense of 9.4 M or Selling General Administrative of 74 M, as well as many exotic indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0778 or PTB Ratio of 37.83. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.

This module can also supplement Establishment Labs' financial leverage analysis and stock options assessment as well as various Establishment Labs Technical models . Check out the analysis of Establishment Labs Correlation against competitors.

Latest Establishment Labs' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Establishment Labs Holdings over the last few years. It is the total amount of a company’s capital funded by shareholders through the issue and subscription of shares. Establishment Labs' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Establishment Labs' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Establishment Capital Stock Regression Statistics

	Arithmetic Mean	177,575,018
	Geometric Mean	171,825,776
	Coefficient Of Variation	29.05
	Mean Deviation	42,224,157
	Median	145,709,000
	Standard Deviation	51,582,707
	Sample Variance	2660.8T
	Range	169.9M
	R-Value	0.78
	Mean Square Error	1124.8T
	R-Squared	0.61
	Significance	0.0006
	Slope	8,989,728
	Total Sum of Squares	37250.9T

Establishment Capital Stock History

	2024	232.1 M
	2023	315.6 M
	2022	223.6 M
	2021	219.7 M
	2020	213.5 M
	2019	147.7 M

Other Fundumenentals of Establishment Labs

Issuance Of Capital Stock

Establishment Labs Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Capital Surpluse	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Invested Capital	Net Working Capital	Long Term Debt Total	Capital Stock
Total Assets		0.61	0.42	0.24	0.45	-0.93	0.74	0.98	0.87	0.9	0.81	-0.47	-0.84	0.98	0.39	-0.89	0.95	0.98	0.8	0.88	0.99	0.94	0.89	0.91
Total Stockholder Equity	0.61		0.94	-0.26	-0.27	-0.5	0.25	0.52	0.79	0.5	0.21	-0.2	-0.8	0.73	0.4	-0.85	0.53	0.73	0.19	0.34	0.6	0.8	0.61	0.41
Net Tangible Assets	0.42	0.94		-0.38	-0.55	-0.24	-0.07	0.32	0.63	0.25	-0.08	0.13	-0.68	0.57	0.38	-0.71	0.31	0.56	-0.1	0.07	0.41	0.65	0.47	0.17
Current Deferred Revenue	0.24	-0.26	-0.38		0.48	-0.29	0.39	0.29	0.27	0.42	0.43	-0.28	-0.24	0.14	-0.71	-0.01	0.37	0.11	0.42	0.34	0.18	-0.01	0.03	0.32
Net Debt	0.45	-0.27	-0.55	0.48		-0.66	0.85	0.54	0.19	0.61	0.87	-0.76	-0.12	0.32	0.03	-0.17	0.52	0.33	0.88	0.78	0.48	0.25	0.32	0.62
Retained Earnings	-0.93	-0.5	-0.24	-0.29	-0.66		-0.91	-0.93	-0.81	-0.97	-0.94	0.72	0.76	-0.9	-0.31	0.83	-0.91	-0.91	-0.93	-0.97	-0.93	-0.86	-0.84	-0.93
Accounts Payable	0.74	0.25	-0.07	0.39	0.85	-0.91		0.78	0.6	0.87	0.95	-0.91	-0.53	0.67	0.14	-0.58	0.81	0.69	0.95	0.92	0.75	0.62	0.61	0.86
Net Receivables	0.98	0.52	0.32	0.29	0.54	-0.93	0.78		0.85	0.91	0.83	-0.49	-0.82	0.94	0.32	-0.85	0.96	0.95	0.83	0.89	0.97	0.89	0.88	0.9
Good Will	0.87	0.79	0.63	0.27	0.19	-0.81	0.6	0.85		0.87	0.62	-0.42	-1.0	0.91	0.11	-0.95	0.84	0.9	0.6	0.7	0.83	0.88	0.78	0.69
Capital Surpluse	0.9	0.5	0.25	0.42	0.61	-0.97	0.87	0.91	0.87		0.9	-0.69	-0.83	0.88	0.12	-0.84	0.89	0.87	0.89	0.93	0.88	0.82	0.79	0.87
Total Liab	0.81	0.21	-0.08	0.43	0.87	-0.94	0.95	0.83	0.62	0.9		-0.8	-0.56	0.73	0.21	-0.62	0.8	0.73	1.0	0.99	0.82	0.68	0.67	0.86
Deferred Long Term Liab	-0.47	-0.2	0.13	-0.28	-0.76	0.72	-0.91	-0.49	-0.42	-0.69	-0.8		0.35	-0.42	-0.05	0.4	-0.55	-0.44	-0.8	-0.75	-0.49	-0.41	-0.34	-0.61
Short Long Term Debt	-0.84	-0.8	-0.68	-0.24	-0.12	0.76	-0.53	-0.82	-1.0	-0.83	-0.56	0.35		-0.9	-0.11	0.95	-0.81	-0.88	-0.54	-0.65	-0.81	-0.87	-0.76	-0.64
Total Current Assets	0.98	0.73	0.57	0.14	0.32	-0.9	0.67	0.94	0.91	0.88	0.73	-0.42	-0.9		0.42	-0.95	0.91	0.99	0.72	0.82	0.98	0.98	0.9	0.85
Treasury Stock	0.39	0.4	0.38	-0.71	0.03	-0.31	0.14	0.32	0.11	0.12	0.21	-0.05	-0.11	0.42		-0.4	0.2	0.44	0.21	0.31	0.46	0.55	0.47	0.3
Short Term Debt	-0.89	-0.85	-0.71	-0.01	-0.17	0.83	-0.58	-0.85	-0.95	-0.84	-0.62	0.4	0.95	-0.95	-0.4		-0.79	-0.94	-0.6	-0.73	-0.88	-0.96	-0.86	-0.69
Intangible Assets	0.95	0.53	0.31	0.37	0.52	-0.91	0.81	0.96	0.84	0.89	0.8	-0.55	-0.81	0.91	0.2	-0.79		0.93	0.79	0.83	0.92	0.83	0.83	0.94
Common Stock	0.98	0.73	0.56	0.11	0.33	-0.91	0.69	0.95	0.9	0.87	0.73	-0.44	-0.88	0.99	0.44	-0.94	0.93		0.71	0.81	0.97	0.97	0.92	0.88
Property Plant Equipment	0.8	0.19	-0.1	0.42	0.88	-0.93	0.95	0.83	0.6	0.89	1.0	-0.8	-0.54	0.72	0.21	-0.6	0.79	0.71		0.98	0.81	0.67	0.64	0.85
Long Term Debt	0.88	0.34	0.07	0.34	0.78	-0.97	0.92	0.89	0.7	0.93	0.99	-0.75	-0.65	0.82	0.31	-0.73	0.83	0.81	0.98		0.89	0.79	0.75	0.87
Net Invested Capital	0.99	0.6	0.41	0.18	0.48	-0.93	0.75	0.97	0.83	0.88	0.82	-0.49	-0.81	0.98	0.46	-0.88	0.92	0.97	0.81	0.89		0.95	0.89	0.9
Net Working Capital	0.94	0.8	0.65	-0.01	0.25	-0.86	0.62	0.89	0.88	0.82	0.68	-0.41	-0.87	0.98	0.55	-0.96	0.83	0.97	0.67	0.79	0.95		0.88	0.78
Long Term Debt Total	0.89	0.61	0.47	0.03	0.32	-0.84	0.61	0.88	0.78	0.79	0.67	-0.34	-0.76	0.9	0.47	-0.86	0.83	0.92	0.64	0.75	0.89	0.88		0.82
Capital Stock	0.91	0.41	0.17	0.32	0.62	-0.93	0.86	0.9	0.69	0.87	0.86	-0.61	-0.64	0.85	0.3	-0.69	0.94	0.88	0.85	0.87	0.9	0.78	0.82

Click cells to compare fundamentals

About Establishment Labs Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Establishment Labs income statement, its balance sheet, and the statement of cash flows. Establishment Labs investors use historical funamental indicators, such as Establishment Labs's Capital Stock, to determine how well the company is positioned to perform in the future. Although Establishment Labs investors may use each financial statement separately, they are all related. The changes in Establishment Labs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Establishment Labs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Establishment Labs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Establishment Labs. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	315.6 M	232.1 M
Issuance Of Capital Stock	76.1 M	51.3 M

Pair Trading with Establishment Labs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Establishment Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Establishment Labs will appreciate offsetting losses from the drop in the long position's value.

Moving against Establishment Stock

0.92	MMSI	Merit Medical Systems	Pair Corr
0.87	SSY	SunLink Health Systems	Pair Corr
0.85	TFX	Teleflex Incorporated Earnings Call This Week	Pair Corr
0.82	CTKB	Cytek Biosciences Financial Report 14th of May 2024	Pair Corr
0.66	DRMA	Dermata Therapeutics Financial Report 9th of May 2024	Pair Corr

The ability to find closely correlated positions to Establishment Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Establishment Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Establishment Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Establishment Labs Holdings to buy it.

The correlation of Establishment Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Establishment Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Establishment Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Establishment Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:

How To Invest In Establishment

Details

Is Establishment Stock a good investment?

Details

What is Establishment Labs' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Establishment Labs Correlation against competitors.

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Establishment Stock analysis

When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.

	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges

Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.07)

Revenue Per Share

6.451

Quarterly Revenue Growth

(0.28)

Return On Assets

(0.17)

Return On Equity

(15.38)

The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Establishment Capital Stock from 2010 to 2024

Latest Establishment Labs' Capital Stock Growth Pattern

Establishment Capital Stock Regression Statistics

Establishment Capital Stock History

Other Fundumenentals of Establishment Labs

Establishment Labs Capital Stock component correlations

About Establishment Labs Financial Statements

Pair Trading with Establishment Labs

Moving against Establishment Stock

Complementary Tools for Establishment Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY